Glucose concentrations after insulin-induced hypoglycemia and glycemic variability in healthy and diabetic cats.

about

Glucose concentrations after insulin-induced hypoglycemia and glycemic variability in healthy and diabetic cats.

Item

http://www.wikidata.org/entity/Q54982674

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Glucose concentrations after i ...... in healthy and diabetic cats.

@en

Glucose concentrations after i ...... in healthy and diabetic cats.

@nl

type

Item

label

Glucose concentrations after i ...... in healthy and diabetic cats.

@en

Glucose concentrations after i ...... in healthy and diabetic cats.

@nl

prefLabel

Glucose concentrations after i ...... in healthy and diabetic cats.

@en

Glucose concentrations after i ...... in healthy and diabetic cats.

@nl

P1476

Glucose concentrations after i ...... y in healthy and diabetic cats

@en

P2093

Claudia E Reusch

http://www.w3.org/2001/XMLSchema#string

Elena Salesov

http://www.w3.org/2001/XMLSchema#string

Laura Moretto

http://www.w3.org/2001/XMLSchema#string

Perrine Dupont

http://www.w3.org/2001/XMLSchema#string

Thomas A Lutz

http://www.w3.org/2001/XMLSchema#string

P2860

Glycemic Variability: How Do We Measure It and Why Is It Important?

In search of the Somogyi effect.

Glucose variability: An emerging target for the treatment of diabetes mellitus.

Glucose variability.

Rebound hyperglycaemia in diabetic cats.

Predictors of clinical remission in cats with diabetes mellitus.

Pharmacodynamics of insulin detemir and insulin glargine assessed by an isoglycemic clamp method in healthy cats.

Evaluation of a novel real-time continuous glucose-monitoring system for use in cats.

Effects of insulin, glucagon and adrenocorticotrophin on the levels of corticosteroids, noradrenaline, adrenaline and ascorbic acid in the adrenal glands of cats.

Association between glucose variability as assessed by continuous glucose monitoring (CGM) and diabetic retinopathy in type 1 and type 2 diabetes.

P304

978-985

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JVIM.15134

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Barbara Contiero

Eric Zini

P577

2018-03-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29603806

http://www.w3.org/2001/XMLSchema#string

P921

hypoglycemia

P932

5980264

http://www.w3.org/2001/XMLSchema#string